Dr. Monjri Manhar Shah, MD

Dr. Shah practices at Birmingham Hematology Oncology Assoc in Mountain Brk, Alabama.

Dr. Shah's NPI, 1275791592, was assigned on May 23, 2008. Dr. Shah graduated from Columbia University College of Physicians and Surgeons in 2005. Dr. Shah holds Alabama license 30991.

Dr. Shah's primary practice is Birmingham Hematology Oncology Assoc, at 500 Office Park Dr, Mountain Brk, AL 35223 in Jefferson County. The practice phone is (205) 870-4783.

Dr. Shah's primary practice is Birmingham Hematology Oncology Assoc in Mountain Brk, Alabama. Dr. Shah is also affiliated with Grandview Medical Center. The medical group on file is Alabama Oncology. Dmand AI also links Dr. Shah to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shah practices, 4 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Shah's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dmand AI has Dr. Shah's licenses on file in 2 states: Alabama and New York.

CMS data shows 310 Medicare services from Dr. Shah across 8 procedure codes in 2024, for 160 Medicare patients. Medicare paid $33,036 for them.

CMS counts 160 Medicare patients who saw Dr. Shah in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Shah's median patient age at 62, with 99% women.

In 2024, Dr. Shah wrote 380 Medicare Part D claims for 188 patients. 94% of them were for generic drugs. CMS names the drug for 293 of them, across 13 drugs with 11 or more claims each, at $11,482 in total drug cost. In 2023, CMS named 289 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Shah for performance year 2024, reported as part of a group. Dr. Shah accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 34 procedures of removal of the uterus by Dr. Shah, more than 98% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 17 papers to Dr. Shah, published from 2010 to 2014. 2014 was the busiest year, with 5. The most frequent topics are Ovarian Neoplasms, Carcinoma, Ovarian Epithelial and Guideline Adherence. Dr. Shah has published most often in Gynecol Oncol. Dr. Shah's most frequent co-authors are Jason D. Wright, MD, Charles N. Landen, MD and Zachary Christopher Dobbin, MD, PhD.

CMS Open Payments shows 133 general payments to Dr. Shah from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $438.

Dr. Shah graduated from Columbia University College of Physicians and Surgeons in 2005.